Mepha Ltd. clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd., Oct 14, 2011 · source ↗
The registry lists 3 studies whose lead sponsor is Mepha Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 24, 2010.
- 3studies on the registry
- 0open to participants now
Before and after it joined Teva Pharmaceutical Industries, Ltd.
- First submitted before Mepha Ltd. became part of Teva Pharmaceutical Industries, Ltd.
- 3
- First submitted after Mepha Ltd. became part of Teva Pharmaceutical Industries, Ltd.
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
What it is testing
The drugs Mepha Ltd.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.
Studies, none open
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed3100%
Over the years
- 207
- 08
- 09
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Mepha Ltd.3 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Teva Pharmaceutical Industries, Ltd. studies →
- Efficacy and Safety of Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infections in AdultsCompletedNCT01092351Phase 4
Sponsor listed in the registry: Mepha Ltd. · First submitted before Mepha Ltd. became part of Teva Pharmaceutical Industries, Ltd.
- Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated MalariaCompletedNCT00978172Phase 4
Sponsor listed in the registry: Mepha Ltd. · First submitted before Mepha Ltd. became part of Teva Pharmaceutical Industries, Ltd.
- Esomeprazole Bioavailability Study With 40 mg Oral Single Dose Fasted and Fed AdministrationCompletedNCT00889850Phase 1
Sponsor listed in the registry: Mepha Ltd. · First submitted before Mepha Ltd. became part of Teva Pharmaceutical Industries, Ltd.